Shiizaki, K <br/><br/>
Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism.  [electronic resource] 

 -  Kidney international  Aug 2006 
 - 486-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0085-2538 
<br/><br/><label>Standard No.: </label>10.1038/sj.ki.5001564  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Bone and Bones--metabolism<br/>Calcitriol--analogs & derivatives<br/>Chronic Kidney Disease-Mineral and Bone Disorder--drug therapy<br/>Hyperparathyroidism, Secondary--complications<br/>Hyperplasia<br/>Immunohistochemistry<br/>Injections, Intralesional<br/>Kidney Failure, Chronic--complications<br/>Male<br/>Organ Size<br/>Parathyroid Glands--pathology<br/>Parathyroid Hormone--genetics<br/>Periosteum--metabolism<br/>Proliferating Cell Nuclear Antigen--metabolism<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Calcitriol--genetics<br/>Receptors, Calcium-Sensing--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction